• $375.6M
    Market Cap
  • N/A
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Top Holders

Institutional
Mutual Funds
No data found

No data found

Current Ownership Distribution

  • Other52.8M (72.15%)
  • Insiders19.9M (27.22%)
  • Mutual Funds461,259 (0.63%)
  • Institutions0 (0.00%)

Insider Transactions

  • 27.22% (19.9M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Heine Josh
VP, Corporate Controller
Exempt
Sep 08, 2026
$0.00
163
$0.00
17,091
Heine Josh
VP, Corporate Controller
Exempt
Sep 08, 2026
$0.00
163
$0.00
2,353
Heine Josh
VP, Corporate Controller
In Kind
Sep 08, 2026
$295.68
48
$6.16
2,305
Tarapchak Richard C
Chief Financial Officer
Exempt
Jun 09, 2026
$0.00
300,000
$0.00
574,910
Miles Aaron Nathaniel
Chief Investment Officer
Exempt
Jun 09, 2026
$0.00
200,000
$0.00
571,478
McDermott Edward Aloysious III
Chief Operating Officer
Exempt
Jun 09, 2026
$0.00
300,000
$0.00
612,326
Kalesnik Laura Marie
See remarks
Exempt
Jun 09, 2026
$0.00
250,000
$0.00
668,059
Tarapchak Richard C
Chief Financial Officer
In Kind
Jun 09, 2026
$94,932.00
87,900
$1.08
487,010
Miles Aaron Nathaniel
Chief Investment Officer
In Kind
Jun 09, 2026
$63,288.00
58,600
$1.08
512,878
McDermott Edward Aloysious III
Chief Operating Officer
In Kind
Jun 09, 2026
$93,150.00
86,250
$1.08
526,076
Kalesnik Laura Marie
See remarks
In Kind
Jun 09, 2026
$65,745.00
60,875
$1.08
607,184